Impact of Utilizing a Composite Versus a Symptom-Only Validation Standard in the Development of the Asthma Impairment and Risk Questionnaire
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Nathan R, Sorkness C, Kosinski M, Schatz M, Li J, Marcus P
. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004; 113(1):59-65.
DOI: 10.1016/j.jaci.2003.09.008.
View
2.
Beuther D, Murphy K, Zeiger R, Wise R, McCann W, Reibman J
. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations. J Allergy Clin Immunol Pract. 2022; 10(12):3204-3212.e2.
DOI: 10.1016/j.jaip.2022.08.017.
View
3.
Chipps B, Zeiger R, Beuther D, Reibman J, Wise R, McCann W
. The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control. Ann Allergy Asthma Immunol. 2023; 131(4):436-443.e1.
DOI: 10.1016/j.anai.2023.04.024.
View
4.
Murphy K, Chipps B, Beuther D, Wise R, McCann W, Gilbert I
. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure. J Allergy Clin Immunol Pract. 2020; 8(7):2263-2274.e5.
DOI: 10.1016/j.jaip.2020.02.042.
View
5.
Reibman J, Chipps B, Zeiger R, Beuther D, Wise R, McCann W
. Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence. J Asthma Allergy. 2023; 16:59-72.
PMC: 9829987.
DOI: 10.2147/JAA.S373184.
View